← Back to all trials
Active Not Recruiting
NCT04301765
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
Conditions: Hypogonadism, Male, Cancer, Fatigue
Sex: Male
Ages: 55 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 230
Sponsor: Seattle Institute for Biomedical and Clinical Research
Location: Georgia Cancer Center at Augusta University Augusta Georgia
Summary
This is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.
Eligibility Criteria
Inclusion Criteria:
* Men with active solid or hematologic (blood) cancers who have received or are receiving chemo- and/or radiation therapy. Patients who have no evidence of disease (NED) for 60 months or less, which means that they are \
Source: ClinicalTrials.gov (NCT04301765). StuddyBuddy aggregates publicly available trial information.
